Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207733
Company: CROWN LABS INC

Products on ANDA 207733

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 207733

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/26/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 207733

NYSTATIN

CREAM;TOPICAL; 100,000 UNITS/GM
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	062949	ACTAVIS MID ATLANTIC
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	061966	COSETTE
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	207733	CROWN LABS INC
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	062129	FOUGERA PHARMS
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	213566	MACLEODS PHARMS LTD
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	062225	PADAGIS US
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	064022	TARO
NYSTATIN	NYSTATIN	100,000 UNITS/GM	CREAM;TOPICAL	Prescription	No	AT	212557	TORRENT